Wegovy Pills for Obesity or Overweight Care Planning We treat obesity or overweight as medical conditions, not moral failures
Safety Concerns When Combining Growth Hormone and GLP-1 Therapy The primary safety consideration is additive gastrointestinal effects
GLP-1 Injections A GLP-1 injection is often used to help manage type 2 diabetes and can lead to more manageable weight loss
Compounded Semaglutide Semaglutide is a GLP-1 receptor agonist that mimics the incretin hormone GLP-1, stimulating insulin secretion, suppressing glucagon, and, critically for weight management, sending satiety signals to the hypothalamus
Zinc as a possible preventive and therapeutic agent in pancreatic, prostate, and breast cancer
Injections are subcutaneous (under the skin), typically into the abdomen, thigh, or upper arm, and injection sites should be rotated weekly to prevent tissue buildup at any one spot